Let's see where the share price is when phase 2 trials for canines and humans have been successful and show a reduction in tumour size.
Let's see what happens when our phase 2 trial using PPL-1 with existing treatments is successful by increasing efficacy without any added side effects.
Let's see when maybe Japanese pharmas are named and how they will commercalise our product to sell internationally or potentially put in a take over bid.
Just too many positives not to be topping up when funds become available. Too often people confuse the share price day to day movements with how well the company is going, laughable really.
PAA Price at posting:
1.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)